Who are Corticosteroid boluses Methylprednisolone's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Oral prednisolone Taper, standard prednisolone treatment, Methyl Prednisolonate, prednison, Azenil, Depo-Medrol, Prednisolone, prednisone, or methylprednisolone.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/corticosteroid-boluses-methylprednisolone.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Corticosteroid boluses Methylprednisolone — Competitive Intelligence Brief

Corticosteroid boluses Methylprednisolone (Corticosteroid boluses Methylprednisolone) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Corticosteroid (glucocorticoid). Area: Immunology / Rheumatology / Neurology.

phase 3 Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR) Immunology / Rheumatology / Neurology Small molecule Live · refreshed every 30 min

Target snapshot

Corticosteroid boluses Methylprednisolone (Corticosteroid boluses Methylprednisolone) — Hospices Civils de Lyon. Methylprednisolone is a synthetic corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Corticosteroid boluses Methylprednisolone TARGET	Corticosteroid boluses Methylprednisolone	Hospices Civils de Lyon	phase 3	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
Oral prednisolone Taper	Oral prednisolone Taper	Berinstein, Jeffrey	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
standard prednisolone treatment	standard prednisolone treatment	Institute of Child Health	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
Methyl Prednisolonate	Methyl Prednisolonate	Ain Shams University	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
prednison, Azenil	prednison, Azenil	Tel-Aviv Sourasky Medical Center	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)
Depo-Medrol	Depo-Medrol	Hamilton Health Sciences Corporation	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor
Prednisolone, prednisone, or methylprednisolone	Prednisolone, prednisone, or methylprednisolone	Children's Hospital of Philadelphia	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Corticosteroid (glucocorticoid) class)

Assistance Publique - Hôpitaux de Paris · 3 drugs in this class
Astellas Pharma Inc · 2 drugs in this class
Sanofi · 2 drugs in this class
Xinqiao Hospital of Chongqing · 2 drugs in this class
Berinstein, Jeffrey · 2 drugs in this class
Ain Shams University · 2 drugs in this class
Children's Hospital of Philadelphia · 1 drug in this class
Celgene · 1 drug in this class
Hamilton Health Sciences Corporation · 1 drug in this class
Erasme University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Corticosteroid boluses Methylprednisolone — Competitive Intelligence Brief. https://druglandscape.com/ci/corticosteroid-boluses-methylprednisolone. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab